Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-15-008270
Filing Date
2015-10-19
Accepted
2015-10-19 21:00:27
Documents
1
Period of Report
2015-10-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1502417_x1-welch.html 4  
1 OWNERSHIP DOCUMENT t1502417_x1-welch.xml 4 7571
  Complete submission text file 0001571049-15-008270.txt   9116
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 JOSHUA VALLEY ROAD EAST LYME CT 06333
Business Address
Welch Daniel A (Reporting) CIK: 0001603461 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 151165331